![wuxi advanced therapies tessa aav scalable production](https://advancedtherapies.com/wp-content/uploads/2024/05/wuxi-advanced-therapies-tessa-aav-scalable-production-850x1024.webp)
Pioneering Scalable Solutions in AAV Manufacturing and Testing for Gene Therapy
To launch a successful GMP program for biologics, a robust quality control (QC) release testing protocol is essential. QC testing, which is mandated by global regulatory authorities, helps ensure that a product meets scientific specifications and reaches patients safely. Though each program will have unique parameters, QC testing should gather data to answer the following questions: